Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 96

1.

The DNA Endonuclease Mus81 Regulates ZEB1 Expression and Serves as a Target of BET4 Inhibitors in Gastric Cancer.

Yin Y, Liu W, Shen Q, Zhang P, Wang L, Tao R, Li H, Ma X, Zeng X, Cheong JH, Song S, Ajani JA, Mills GB, Tao K, Peng G.

Mol Cancer Ther. 2019 Aug;18(8):1439-1450. doi: 10.1158/1535-7163.MCT-18-0833. Epub 2019 May 29.

PMID:
31142662
2.

MUS81 Inhibition Increases the Sensitivity to Therapy Effect in Epithelial Ovarian Cancer via Regulating CyclinB Pathway.

Zhong A, Zheng H, Zhang H, Sun J, Shen J, Deng M, Chen M, Lu R, Guo L.

J Cancer. 2019 May 21;10(10):2276-2287. doi: 10.7150/jca.30818. eCollection 2019.

3.

MicroRNA-574-3p regulates epithelial mesenchymal transition and cisplatin resistance via targeting ZEB1 in human gastric carcinoma cells.

Wang M, Zhang R, Zhang S, Xu R, Yang Q.

Gene. 2019 Jun 5;700:110-119. doi: 10.1016/j.gene.2019.03.043. Epub 2019 Mar 24.

PMID:
30917930
4.

HIF-1α Promotes Epithelial-Mesenchymal Transition and Metastasis through Direct Regulation of ZEB1 in Colorectal Cancer.

Zhang W, Shi X, Peng Y, Wu M, Zhang P, Xie R, Wu Y, Yan Q, Liu S, Wang J.

PLoS One. 2015 Jun 9;10(6):e0129603. doi: 10.1371/journal.pone.0129603. eCollection 2015.

5.

53BP1 suppresses epithelial-mesenchymal transition by downregulating ZEB1 through microRNA-200b/429 in breast cancer.

Kong X, Ding X, Li X, Gao S, Yang Q.

Cancer Sci. 2015 Aug;106(8):982-9. doi: 10.1111/cas.12699. Epub 2015 Jul 14.

6.

Src promotes EGF-induced epithelial-to-mesenchymal transition and migration in gastric cancer cells by upregulating ZEB1 and ZEB2 through AKT.

Zhao L, Li X, Song N, Li A, Hou K, Qu X, Che X, Liu Y.

Cell Biol Int. 2018 Mar;42(3):294-302. doi: 10.1002/cbin.10894. Epub 2017 Nov 15.

PMID:
29052277
7.

Direct repression of MYB by ZEB1 suppresses proliferation and epithelial gene expression during epithelial-to-mesenchymal transition of breast cancer cells.

Hugo HJ, Pereira L, Suryadinata R, Drabsch Y, Gonda TJ, Gunasinghe NP, Pinto C, Soo ET, van Denderen BJ, Hill P, Ramsay RG, Sarcevic B, Newgreen DF, Thompson EW.

Breast Cancer Res. 2013 Nov 27;15(6):R113. doi: 10.1186/bcr3580.

8.

LncRNA PTAR promotes EMT and invasion-metastasis in serous ovarian cancer by competitively binding miR-101-3p to regulate ZEB1 expression.

Liang H, Yu T, Han Y, Jiang H, Wang C, You T, Zhao X, Shan H, Yang R, Yang L, Shan H, Gu Y.

Mol Cancer. 2018 Aug 11;17(1):119. doi: 10.1186/s12943-018-0870-5.

9.

RAE1 mediated ZEB1 expression promotes epithelial-mesenchymal transition in breast cancer.

Oh JH, Lee JY, Yu S, Cho Y, Hur S, Nam KT, Kim MH.

Sci Rep. 2019 Feb 27;9(1):2977. doi: 10.1038/s41598-019-39574-8.

10.

LncRNA ADPGK-AS1 promotes pancreatic cancer progression through activating ZEB1-mediated epithelial-mesenchymal transition.

Song S, Yu W, Lin S, Zhang M, Wang T, Guo S, Wang H.

Cancer Biol Ther. 2018 Jul 3;19(7):573-583. doi: 10.1080/15384047.2018.1423912. Epub 2018 Apr 19.

11.

MiR-652 inhibits acidic microenvironment-induced epithelial-mesenchymal transition of pancreatic cancer cells by targeting ZEB1.

Deng S, Li X, Niu Y, Zhu S, Jin Y, Deng S, Chen J, Liu Y, He C, Yin T, Yang Z, Tao J, Xiong J, Wu H, Wang C, Zhao G.

Oncotarget. 2015 Nov 24;6(37):39661-75. doi: 10.18632/oncotarget.5350.

12.

LncRNA SNHG6 is Associated with Poor Prognosis of Gastric Cancer and Promotes Cell Proliferation and EMT through Epigenetically Silencing p27 and Sponging miR-101-3p.

Yan K, Tian J, Shi W, Xia H, Zhu Y.

Cell Physiol Biochem. 2017;42(3):999-1012. doi: 10.1159/000478682. Epub 2017 Jun 27.

13.

The nuclear protein expression levels of SNAI1 and ZEB1 are involved in the progression and lymph node metastasis of cervical cancer via the epithelial-mesenchymal transition pathway.

Chen Z, Li S, Huang K, Zhang Q, Wang J, Li X, Hu T, Wang S, Yang R, Jia Y, Sun H, Tang F, Zhou H, Shen J, Ma D, Wang S.

Hum Pathol. 2013 Oct;44(10):2097-105. doi: 10.1016/j.humpath.2013.04.001. Epub 2013 Jun 20.

PMID:
23791009
14.

CUL4A induces epithelial-mesenchymal transition and promotes cancer metastasis by regulating ZEB1 expression.

Wang Y, Wen M, Kwon Y, Xu Y, Liu Y, Zhang P, He X, Wang Q, Huang Y, Jen KY, LaBarge MA, You L, Kogan SC, Gray JW, Mao JH, Wei G.

Cancer Res. 2014 Jan 15;74(2):520-31. doi: 10.1158/0008-5472.CAN-13-2182. Epub 2013 Dec 4.

15.

ISL1 predicts poor outcomes for patients with gastric cancer and drives tumor progression through binding to the ZEB1 promoter together with SETD7.

Guo T, Wen XZ, Li ZY, Han HB, Zhang CG, Bai YH, Xing XF, Cheng XJ, Du H, Hu Y, Wang XH, Jia YN, Nie ML, Xie M, Li QD, Ji JF.

Cell Death Dis. 2019 Jan 15;10(2):33. doi: 10.1038/s41419-018-1278-2.

16.

AKIP1 promoted epithelial-mesenchymal transition of non-small-cell lung cancer via transactivating ZEB1.

Guo X, Zhao L, Cheng D, Mu Q, Kuang H, Feng K.

Am J Cancer Res. 2017 Nov 1;7(11):2234-2244. eCollection 2017.

17.

UBE2C, Directly Targeted by miR-548e-5p, Increases the Cellular Growth and Invasive Abilities of Cancer Cells Interacting with the EMT Marker Protein Zinc Finger E-box Binding Homeobox 1/2 in NSCLC.

Jin D, Guo J, Wu Y, Du J, Wang X, An J, Hu B, Kong L, Di W, Wang W.

Theranostics. 2019 Mar 17;9(7):2036-2055. doi: 10.7150/thno.32738. eCollection 2019.

18.

MTMR2 promotes invasion and metastasis of gastric cancer via inactivating IFNγ/STAT1 signaling.

Jiang L, Liu JY, Shi Y, Tang B, He T, Liu JJ, Fan JY, Wu B, Xu XH, Zhao YL, Qian F, Cui YH, Yu PW.

J Exp Clin Cancer Res. 2019 May 21;38(1):206. doi: 10.1186/s13046-019-1186-z.

19.

Epidermal growth factor-like domain-containing protein 7 (EGFL7) enhances EGF receptor-AKT signaling, epithelial-mesenchymal transition, and metastasis of gastric cancer cells.

Luo BH, Xiong F, Wang JP, Li JH, Zhong M, Liu QL, Luo GQ, Yang XJ, Xiao N, Xie B, Xiao H, Liu RJ, Dong CS, Wang KS, Wen JF.

PLoS One. 2014 Jun 19;9(6):e99922. doi: 10.1371/journal.pone.0099922. eCollection 2014.

20.

ZEB1 promotes the progression and metastasis of cervical squamous cell carcinoma via the promotion of epithelial-mesenchymal transition.

Ma Y, Zheng X, Zhou J, Zhang Y, Chen K.

Int J Clin Exp Pathol. 2015 Sep 1;8(9):11258-67. eCollection 2015.

Supplemental Content

Support Center